EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway

Manuel Johanns iD, Alexandre Berthier iD, Jimmy Vandel, Sandra Courquet iD, Marie Lapage, Julie Dubois-Chevalier iD, Manjula Vinod, Ninon Very, Francesco Paolo Zummo iD, Marie Bobowski-Gérard iD, Georgiana Toma, Céline Gheeraert iD und 7 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2611767123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Manuel Johanns und 18 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, UMR1011-European Genomic Institute for Diabetes, Université de Lille, L…. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Nuclear Receptor Subfamily 1, Group D, Member 1, Signal Transduction, ARNTL Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche (ANR), Fondation pour la Recherche Médicale (FRM), Wallonie-Bruxelles International (WBI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a progressive and life-threatening condition with no effective targeted treatments. Growing evidence indicates a two-way relationship between circadian rhythm and fibrogenesis, although the specific molecular signaling pathways involved are still not well understood. The molecular clock, which governs circadian rhythms, regulates metabolic and cellular functions, and its pharmacological manipulation has shown potential as a therapy for organ fibrosis. Although the liver’s molecular clock appeared resilient to the progression of chronic liver disease in humans from steatosis to fibrosis, detectable changes in the daily amplitude of clock genes were observed in a cohort of people living with obesity. We found a clock-controlled signaling pathway that drives hepatic stellate cell (HSC) activation, a key initiating event in fibrosis progression. Interfering with this pathway, either by disrupting the core regulator CLOCK:BMAL1 or activating the nuclear receptors REV-ERBs, significantly reduced HSC activation. We also identified transgelin as the downstream effector of clock-regulated HSC contractility, a characteristic of HSC activation. Transgelin is regulated indirectly by a BMAL1-CK1ε signaling pathway and directly by REV-ERBα. Our findings identify a hitherto undescribed mechanism that links the molecular clock to HSC activation and cell contractile function, which is relevant to human fibrotic diseases. This pathway provides several entry points for drugs to target and disrupt primary fibrogenic signaling. By connecting clock biology to the cellular processes that cause fibrosis, our work also offers a mechanistic basis for chronotherapeutic strategies against chronic liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsNuclear Receptor Subfamily 1, Group D, Member 1Signal TransductionARNTL Transcription FactorsCircadian ClocksAnimalsHumansLiver CirrhosisMice

Stichwörter der Autor:innen

circadian rhythmicityhepatic stellate cellintracellular signalingnuclear receptor

Substanzen

Nuclear Receptor Subfamily 1, Group D, Member 1ARNTL Transcription FactorsNR1D1 protein, humanBMAL1 protein, human

Autor:innen und Institutionen

  • Inserm, Centre Hospitalier Universitaire de Lille, Institut Pasteur de Lille, UMR1011-European Genomic Institute for Diabetes, Université de Lille, Lille F-59000, France.
  • US 41-Unité d'Appui et de Recherche 2014-Plateformes Lilloises en Biologie et Santé Bilille, CNRS, Inserm, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, Université de Lille, Lille F-59000, France.
  • Université Catholique Louvain, de Duve Institute, MASSPROT-Proteomic & Protein Analysis by Mass Spectrometry, Brussels B-1200, Belgium.
  • Inserm, Centre Hospitalier Universitaire Lille, Institut Pasteur de Lille, U1190-European Genomic Institute for Diabetes, Université de Lille, Lille F-59000, France.
  • Department of General and Endocrine Surgery, Centre Hospitalier Universitaire de Lille, Lille F-59000, France.

ORCID-Profile: Manuel Johanns, Alexandre Berthier, Sandra Courquet, Julie Dubois-Chevalier, Francesco Paolo Zummo, Marie Bobowski-Gérard, Céline Gheeraert, Didier Vertommen, Gaëtan Herinckx, François Pattou, Philippe Lefebvre

Förderung

  • Agence Nationale de la Recherche (ANR)
  • Fondation pour la Recherche Médicale (FRM)
  • Wallonie-Bruxelles International (WBI)
  • European Association for the Study of the Liver (EASL)

Zitieren

APA

Johanns, M., Berthier, A., Vandel, J., Courquet, S., Lapage, M., Dubois-Chevalier, J., Vinod, M., Very, N., Zummo, F. P., Bobowski-Gérard, M., Toma, G., Gheeraert, C., Vertommen, D., Herinckx, G., Raverdy, V., Pattou, F., Staels, B., Eeckhoute, J., & Lefebvre, P. (2026). The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2611767123

Vancouver

Johanns M, Berthier A, Vandel J, Courquet S, Lapage M, Dubois-Chevalier J, et al. The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2611767123

BibTeX
@article{Johanns2026,
  author = {Johanns, Manuel and Berthier, Alexandre and Vandel, Jimmy and Courquet, Sandra and Lapage, Marie and Dubois-Chevalier, Julie and Vinod, Manjula and Very, Ninon and Zummo, Francesco Paolo and Bobowski-Gérard, Marie and Toma, Georgiana and Gheeraert, Céline and Vertommen, Didier and Herinckx, Gaëtan and Raverdy, Violeta and Pattou, François and Staels, Bart and Eeckhoute, Jérôme and Lefebvre, Philippe},
  title = {The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2611767123}
}
Kostenlos starten →